Tech Company Financing Transactions

Morphotek Funding Round

On 10/12/2006, Morphotek raised $40 million in Series D financing from Investor Growth Capital, Burrill & Company and CB Health Ventures.

Transaction Overview

Company Name
Announced On
10/12/2006
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Proceeds Purpose
The funds will be used primarily to further clinical development of the Company's lead therapeutic antibodies, MORAb-003 and MORAb-009, and to advance its pipeline of preclinical antibodies for the treatment of oncology, inflammatory and infectious diseases.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
210 Welsh Pool Road
Exton, PA 19341
USA
Email Address
Not Recorded
Overview
Morphotek is a biopharmaceutical company developing therapeutic monoclonal antibodies through the use of a proprietary human antibody technology.
Profile
Morphotek LinkedIn Company Profile
Social Media
Morphotek Company Twitter Account
Company News
Morphotek News
Facebook
Morphotek on Facebook
YouTube
Morphotek on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nicholas Nicolaides
  Nicholas Nicolaides LinkedIn Profile  Nicholas Nicolaides Twitter Account  Nicholas Nicolaides News  Nicholas Nicolaides on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/10/2006: Achaogen venture capital transaction
Next: 10/12/2006: Greystripe venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary